🔴 Xenetic Biosciences is trading 5.12% down in after-hours trading with no company-specific announcement identified

Xenetic Biosciences is trading 5.12% down at $3.13 after no new company-specific announcement was identified for August 12, 2026.

• The latest release, dated August 7, reported approximately $0.9 million in quarterly net loss, $6.5 million in cash, and an ongoing strategic review.
• Broader markets finished higher, so macro sentiment does not clearly explain the decline. Confidence remains low.